Literature DB >> 28132860

Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.

Joshua R Menke1, George Vasmatzis2, Stephen Murphy2, Lin Yang2, David M Menke3, Han W Tun4, Rebecca L King5, Stephanie A Smoley5, Rhett P Ketterling5, William R Sukov6.   

Abstract

Mantle cell lymphoma (MCL) is typically characterized by t(11;14), which places the IGH@ enhancer elements upstream of CCND1. This fusion results in up-regulation of CCND1 and consequently its protein product cyclin D1. Recent studies have shown that in MCL, mutations or translocations occurring within the 3' untranslated region (UTR) of the CCND1 gene can result in a truncated mRNA transcript that is more stable and associated with more aggressive disease. We identified a case of MCL showing cyclin D1 overexpression by immunohistochemistry and a t(11;12)(q13;p11.2) by conventional cytogenetic studies. Next-generation genomic sequencing indicated a chromosomal break through the CCND1 3'-UTR and fusion with a non-coding region of chromosome 12. We suggest that, in the absence of the typical CCND1/IGH@ fusion, this rearrangement promotes MCL pathogenesis by eliminating miRNA interaction elements within the 3'-UTR of the CCND1 mRNA transcript consequently resulting in CCND1 overexpression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3′-UTR; CCND1; Cytogenetics; Mantle cell lymphoma; Mate-pair sequencing; Translocation; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28132860     DOI: 10.1016/j.humpath.2017.01.001

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies.

Authors:  Jess F Peterson; Linda B Baughn; Rhett P Ketterling; Beth A Pitel; Stephanie A Smoley; George Vasmatzis; James B Smadbeck; Patricia T Greipp; Abhishek A Mangaonkar; Carrie A Thompson; Sameer A Parikh; Dong Chen; David S Viswanatha
Journal:  Blood Adv       Date:  2019-04-23

2.  Truncation of 3' CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma.

Authors:  Fumiyo Maekawa; Chiyuki Kishimori; Miho Nakagawa; Kayo Takeoka; Katsuhiro Fukutsuka; Masahiko Hayashida; Futoshi Iioka; Masakazu Fujimoto; Kengo Takeuchi; Hirokazu Nakamine; Hitoshi Ohno
Journal:  Blood Adv       Date:  2021-01-12

Review 3.  Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas.

Authors:  Shenon Sethi; Zachary Epstein-Peterson; Anita Kumar; Caleb Ho
Journal:  Front Oncol       Date:  2021-11-23       Impact factor: 6.244

4.  Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma.

Authors:  Joanna C Dalland; James B Smadbeck; Neeraj Sharma; Reid G Meyer; Kathryn E Pearce; Patricia T Greipp; Jess F Peterson; Shaji Kumar; Rhett P Ketterling; Rebecca L King; Linda B Baughn
Journal:  Genes Chromosomes Cancer       Date:  2021-06-22       Impact factor: 5.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.